oasis trial semaglutide Low Dose Oral for Overweight Adults (OASIS-4) | NEJM ECO 2026 - OASIS 4:

This study investigated the potential association between GLP-1RAs and SSIBs by exploring the FDA Adverse Event Reporting System (FAERS) database

Postgraduate Medicine

These reductions were attributed primarily to decreased appetite, lower food cravings, and reduced energy intake, aligning with earlier findings in animal models

Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants

Mitochondrial dysfunction, insulin resistance, and glucose metabolism abnormalities collectively lead to insufficient energy supply and neuronal damage, with insulin resistance and mitochondrial dysfunction being key pathways affecting energy metabolism imbalance in PD patients

Increasing evidence suggests a strong pathophysiological connection between AD and Diabetes Mellitus Type II (DM2), which is characterized by insulin resistance and subsequent pancreatic islet -cell failure, leading to insufficient insulin levels for normal glucose metabolism 3,4,5,6